Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Navigator Medicines operate as a biotech company.
Elektrofi develops hyper concentration microparticle technology for subcutaneous biologic medicine delivery.
Halda Therapeutics is a research-stage drug discovery company.
Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
Vesta Healthcare is a technology and clinical services organization that offers virtual care services.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
AM Batteries manufactures Li-ion batteries using solvent-free electrode manufacturing technology.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Life Science. The firm invests across 21 different industry categories.
Among tracked funding rounds, Bluejay Therapeutics received $182.0M in a Series C round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include Alentis Therapeutics, Trace Neuroscience, Avalo Therapeutics, Alpha-9 Oncology, Enara Bio. These companies were founded in 2020 or later.